Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
2.
Molecules ; 21(11)2016 Nov 22.
Article in English | MEDLINE | ID: mdl-27879673

ABSTRACT

Obesity and insulin resistance (IR) are interdependent multifactorial processes that cannot be understood separately. Obesity leads to systemic inflammation and increased levels of free fatty acids that provoke IR and lipotoxicity. At the same time, IR exacerbates adipose cell dysfunction, resulting in chronic inflammation and major lipotoxic effects on nonadipose tissues. 4-Hydroxyisoleucine (4-OHIle), a peculiar nonprotein amino acid isolated from fenugreek (Trigonella foenum-graecum) seeds, exhibits interesting effects on IR related to obesity. 4-OHIle increases glucose-induced insulin release, and the insulin response mediated by 4-OHIle depends on glucose concentration. The beneficial effects observed are related to the regulation of blood glucose, plasma triglycerides, total cholesterol, free fatty acid levels, and the improvement of liver function. The mechanism of action is related to increased Akt phosphorylation and reduced activation of Jun N-terminal kinase (JNK)1/2, extracellular signal-regulated kinase (ERK)1/2, p38 mitogen-activated protein kinase (MAPK), and nuclear factor (NF)-κB. Here, we present a review of the research regarding the insulinotropic and insulin-sensitising activity of 4-OHIle in in vitro and in vivo models.


Subject(s)
Insulin Resistance , Isoleucine/analogs & derivatives , Obesity/drug therapy , Trigonella/chemistry , Animals , Glucose/metabolism , Humans , In Vitro Techniques , Isoleucine/pharmacology , Isoleucine/therapeutic use , Liver/drug effects , Liver/physiopathology , Liver Function Tests , MAP Kinase Signaling System/drug effects , Obesity/metabolism , Obesity/physiopathology , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
3.
J Pediatr ; 90(2): 218-24, 1977 Feb.
Article in English | MEDLINE | ID: mdl-830913

ABSTRACT

A patient with neonatal onset citrullinemia survived to 8 months of age when treated with a mixture of essential amino acids and their keto-analogues. The initial plasma citrulline concentration was 2.7 mM; the blood ammonia concentration was greater than 500 muM. During the first week of therapy, the blood ammonia concentration became normal and that of plasma citrulline was reduced by almost 50%. It was possible to institute progressive increases in dietary calories and protein; growth and developmetn with resolution of almost all clinical signs of disease ensued. The patient died at 8 months of age after an episode of diarrhea and dehydration, probably of viral origin.


Subject(s)
Amino Acid Metabolism, Inborn Errors/drug therapy , Amino Acids, Essential/therapeutic use , Citrulline/blood , Arginine/therapeutic use , Argininosuccinate Synthase/deficiency , Fibroblasts/enzymology , Histidine/therapeutic use , Humans , Infant , Infant, Newborn , Isoleucine/therapeutic use , Leucine/therapeutic use , Lysine/therapeutic use , Male , Methionine/therapeutic use , Phenylalanine/therapeutic use , Threonine/therapeutic use , Tryptophan/therapeutic use , Valine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL